- Home
- Equities - Stocks - Shares
- Company Press Releases
- MEDESIS PHARMA ANNOUNCES THE CONSTITUTION OF A PERMANENT SCIENTIFIC ADVISORY BOARD OF EXPERTS IN NEURODEGENERATIVE DISEASES
21 Nov 2022 18:00 CET
MEDESIS PHARMA S.A.
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
MEDESIS PHARMA
Les Echos
MEDESIS PHARMA S.A.
FR0010844464
ALMDP
Euronext Growth